National Tay-Sachs & Allied Diseases Association to Hold 60th Anniversary Imagine & Believe Benefit November 9, 2017 BOSTON, Nov. 01, 2017 (GLOBE NEWSWIRE) -- The National Tay-Sachs & Allied Diseases Association (NTSAD), the nation’s longest standing patient advocacy organization, announces that it will honor...

National Tay-Sachs & Allied Diseases Association Forms Jacob's Cure Fund for Canavan Disease Research BOSTON, Oct. 16, 2013 (GLOBE NEWSWIRE) -- National Tay-Sachs & Allied Diseases Association (NTSAD) today announced that it is forming the Jacob's Cure Fund to support research and family services in...

National Tay-Sachs & Allied Diseases Association Receives U.S. Orphan Drug Designation for Novel Gene Therapy BOSTON, June 13, 2013 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to National Tay-Sachs and Allied Diseases Association (NTSAD) for development...

At National Tay-Sachs & Allied Diseases Science Symposium, Leading Neurodegenerative Disease Researchers Present Breakthroughs BOSTON, April 6, 2011 (GLOBE NEWSWIRE) -- Breakthroughs in crossing the blood-brain barrier could lead to new treatments for Tay-Sachs, Canavan and other neurodegenerative diseases. The findings were...